Auro Peptides
Auro Peptides is a peptide CDMO based in India (Hyderabad). Direct manufacturer. Holds US DMFs for semaglutide, liraglutide, calcitonin, degarelix and 11 more API.
Listing reviewed September 2026.
About Auro Peptides
India-based peptide API manufacturing business unit of Aurobindo Pharma. Specializes in peptide active pharmaceutical ingredient development and manufacturing for generic and innovator pharmaceutical markets. Serves global customers with GMP-compliant peptide production capabilities.
Directory assessment: Auro Peptides is listed as a CDMO in the peptide supply chain, serving Asia markets from India (Hyderabad). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 1 source for reference. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.
- Calcitonin: DMF 35791 (Type II, active), submitted 2021-03-30
- Degarelix: DMF 35078 (Type II, active), submitted 2020-08-07
- Desmopressin: DMF 30233 (Type II, active), submitted 2016-02-19
- Etelcalcetide: DMF 35386 (Type II, active), submitted 2020-11-12
- Ganirelix: DMF 36108 (Type II, active), submitted 2021-07-14
- Glatiramer: DMF 35493 (Type II, active), submitted 2020-12-25
- Icatibant: DMF 33750 (Type II, active), submitted 2019-04-03
- Leuprolide: DMF 31170 (Type II, active), submitted 2016-11-30
- Linaclotide: DMF 29708 (Type II, active), submitted 2015-09-22
- Liraglutide: DMF 37793 (Type II, active), submitted 2023-01-27
- Octreotide: DMF 29448 (Type II, active), submitted 2015-06-20
- Plecanatide: DMF 36321 (Type II, active), submitted 2021-09-24
- Semaglutide: DMF 42442 (Type II, active), submitted 2026-03-06
- Teriparatide: DMF 33079 (Type II, active), submitted 2018-08-17
- Vasopressin: DMF 33119 (Type II, active), submitted 2018-08-27
DMF numbers from the FDA quarterly DMF list. A filed DMF is not FDA approval; its contents are confidential. Reviewed 2026-10-23.